XML 20 R6.htm IDEA: XBRL DOCUMENT v3.25.3
Combined Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Operating Activities    
Net income $ 620,000,000 $ 503,000,000
Adjustments to reconcile net income to net cash provided by (used for) operating activities:    
Depreciation 124,000,000 120,000,000
Amortization of definite-lived intangible assets 156,000,000 177,000,000
Stock based compensation 12,000,000 10,000,000
Credit for deferred income tax and other tax related items (61,000,000) (54,000,000)
Net gain on sales of assets (1,000,000) (2,000,000)
Restructuring and asset related charges - net 20,000,000 7,000,000
Net periodic pension benefit cost 6,000,000 4,000,000
Periodic benefit plan contributions (3,000,000) (2,000,000)
Earnings of nonconsolidated affiliates less dividends received (37,000,000) (33,000,000)
Changes in assets and liabilities:    
Accounts and notes receivable (97,000,000) (87,000,000)
Inventories (33,000,000) (84,000,000)
Other assets 13,000,000 (14,000,000)
Accounts payable 81,000,000 149,000,000
Accrued and other current liabilities (6,000,000) 78,000,000
Other noncurrent liabilities (1,000,000) (1,000,000)
Income tax liabilities (11,000,000) 4,000,000
Cash provided by operating activities 782,000,000 775,000,000
Investing Activities    
Capital expenditures (214,000,000) (134,000,000)
Other investing activities, net 0 1,000,000
Cash used for investing activities (214,000,000) (133,000,000)
Financing Activities    
Distributions to noncontrolling interests (21,000,000) (13,000,000)
Net transfers (to) from Parent (2,311,000,000) (611,000,000)
Proceeds from issuance of long-term debt 1,750,000,000 0
Payments for debt issuance costs (34,000,000) 0
Cash used for financing activities (616,000,000) (624,000,000)
Effect of exchange rate changes on cash and cash equivalents 10,000,000 (2,000,000)
(Decrease) increase in cash and cash equivalents (38,000,000) 16,000,000
Cash and cash equivalents at beginning of period 166,000,000 139,000,000
Cash and cash equivalents at end of period $ 128,000,000 $ 155,000,000